Education
About Us
Working with TipRanks
Follow Us
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -174.84K | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -22.22M | $ -17.88M | $ -14.43M | $ -12.59M | $ -5.91M |
| EBITDA | $ -22.20M | $ -15.79M | $ -14.42M | $ -12.58M | $ -5.90M |
| Net Income | $ -20.78M | $ -15.96M | $ -14.26M | $ -12.36M | $ -5.91M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 24.01M | $ 41.30M | $ 55.20M | $ 70.73M | $ 19.23M |
| Total Assets | $ 25.57M | $ 43.65M | $ 58.84M | $ 73.95M | $ 20.36M |
| Total Debt | $ 243.66K | $ 234.47K | $ 52.89K | $ 204.95K | $ 108.50K |
| Net Debt | $ -7.27M | $ -21.70M | $ -37.15M | $ -51.32M | $ -19.12M |
| Total Liabilities | $ 4.38M | $ 2.74M | $ 2.80M | $ 2.38M | $ 660.84K |
| Stockholders' Equity | $ 21.19M | $ 40.91M | $ 56.04M | $ 71.57M | $ 19.70M |
| Cash Flow | |||||
| Free Cash Flow | $ -17.83M | $ -14.37M | $ -12.80M | $ -10.61M | $ -5.67M |
| Operating Cash Flow | $ -17.81M | $ -14.35M | $ -12.77M | $ -10.59M | $ -5.65M |
| Investing Cash Flow | $ 3.37M | $ -930.21K | $ 179.27K | $ -19.53M | $ -16.14K |
| Financing Cash Flow | $ 66.71K | $ -500.00K | $ -2.18M | $ 63.42M | $ 23.66M |
Lantern Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.